Launch Tech Co Ltd Stock
Price
Target price
€0.90
€0.90
0.000%
-
0.000%
-
22.05.26 / Stuttgart Stock Exchange
WKN: A0M4VZ / Name: Launch / Stock / Machinery, Equipment & Components / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Launch Tech Co Ltd Stock
The Launch Tech Co Ltd price is unchanged compared to yesterday.
Pros and Cons of Launch Tech Co Ltd in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Launch Tech Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Launch Tech Co Ltd | 0.000% | -2.174% | 1.124% | -39.597% | -4.459% | 271.901% | 117.391% |
| Chongqing Machinery & Electric Co Ltd | 0.000% | -1.734% | 17.241% | 209.091% | 61.905% | 389.209% | 553.846% |
| Tennant Co. | 0.650% | 0.494% | 5.874% | 8.702% | 12.126% | - | - |
| Jenoptik AG | 3.780% | -0.583% | 31.454% | 131.452% | 126.367% | 45.437% | 85.822% |
News
Takeda Pharmaceutical Q4 Earnings Call Highlights
Takeda Pharmaceutical (NYSE:TAK) reported fiscal 2025 results that management described as solid despite pressure from generic
Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus
Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric
Abeona Therapeutics Q1 Earnings Call Highlights
Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center